Skip to main content
. 2020 Dec 11;5(4):258–266. doi: 10.1089/trgh.2020.0003

Table 2.

Bivariate and Multivariate Linear Regression Analysis of Transgender Women Willingness to Use Pre-Exposure Prophylaxis (n=361)

Variable Bivariate analysis
Multivariable analysis
B SE 95% CI p B SE 95% CI p
Age (mean, SD) −0.03 0.01 (−0.04 to −0.02) <0.001 −0.02 0.01 (−0.03 to −0.01) 0.002
Ethnicity
 Malay 0.25 0.13 (−0.01 to 0.51) 0.062        
 Indian −0.32 0.17 (−0.65 to 0.02) 0.064        
 Chinese −1.38 0.37 (−2.10 to −0.66) <0.001 −1.08 0.35 (−1.76 to −0.39) 0.002
 Income ≥MYR 1000 per month 0.27 0.17 (−0.06 to 0.60) 0.108        
 High school education or higher 0.38 0.12 (0.13 to 0.62) 0.003 0.28 0.13 (0.03 to 0.53) 0.026
 Single 0.04 0.12 (−0.20 to 0.29) 0.743        
 Living in stable housing 0.36 0.07 (−0.16 to 0.89) 0.175        
Sexual risk behaviors
 Sex work (last 6 months) 0.21 0.13 (−0.05 to 0.47) 0.115        
 Sex work clients per day in last month (mean, SD) 0.03 0.01 (0.01 to 0.05) 0.008 0.01 0.01 (−0.01 to 0.03) 0.281
 Solicited sex work clients via mobile app 0.27 0.12 (0.04 to 0.50) 0.024 0.10 0.11 (−0.12 to 0.32) 0.377
 Condomless sex with casual partner(s) (last 6 months) −0.07 0.13 (−0.34 to 0.20) 0.626        
 Condomless sex with primary partner (last 6 months) 0.03 0.13 (−0.24 to 0.29) 0.841        
Sexual and general health
 Previous STI diagnosis (ever) −0.04 0.20 (0.42 to 0.35) 0.854        
 HIV tested in last 12 months 0.16 0.12 (−0.07 to 0.38) 0.167        
 Used HT (last 90 days) 0.28 0.12 (0.06 to 0.51) 0.014        
 Used HT (lifetime) 0.64 0.22 (0.22 to 1.06) 0.003 0.49 0.20 (0.09 to 0.89) 0.016
 Seen by a doctor in last 12 months 0.34 0.16 (0.02 to 0.66) 0.037 0.21 0.15 (−0.10 to 0.51) 0.182
 Current depressive symptoms 0.11 0.12 (−0.12 to 0.34) 0.338        
Drug and alcohol use
 ATS use (last 30 days) −0.52 0.20 (−0.91 to −0.13) 0.010 −0.32 0.19 (−0.69 to 0.05) 0.092
 Alcohol use (last 30 days) 0.20 0.15 (−0.10 to 0.50) 0.194        
 Drug injection behavior (lifetime) −1.17 0.35 (−1.85 to −0.48) 0.001 −0.69 0.33 (−1.34 to −0.03) 0.041
Criminal justice history
 Previously in lockup/jail (lifetime) −0.18 0.12 (−0.41 to 0.06) 0.145        
 Previously in prison (lifetime) −0.04 0.14 (−0.62 to −0.07) 0.015        
 Multiple times in lockup −0.21 0.14 (−0.48 to 0.07) 0.137        
 Multiple times in prison −0.68 0.19 (−1.05 to −0.31) 0.001 −0.27 0.19 (−0.64 to 0.11) 0.166
Physical and sexual trauma
 Childhood physical assault −0.11 0.12 (−0.35 to 0.13) 0.354        
 Childhood sexual assault −0.16 0.12 (−0.39 to 0.08) 0.186        
 Adulthood physical assault −0.32 0.19 (−0.68 to 0.05) 0.086        
 Adulthood sexual assault −0.10 0.14 (−0.38 to 0.18) 0.477        
PrEP and PEP
 Meets WHO criteria for PrEP 0.17 0.15 (−0.12 to 0.46) 0.256        
 Previously heard of PrEP −0.38 0.14 (−0.66 to −0.10) 0.009 −0.25 0.13 (−0.51 to 0.02) 0.066
 Willing to pay for PrEP 1.55 0.18 (1.21 to 1.90) <0.001        
 Prefer using private doctor for PrEP −0.13 0.13 (−0.38 to 0.12) 0.312        
 Amount willing to pay for PrEP each month (MYR) (mean, SD) 0.01 0.01 (0.01 to 0.01) 0.015 0.01 0.01 (0.01 to 0.01) 0.116
 Previously used PEP 0.27 0.14 (0.01 to 0.55) 0.050 0.25 0.13 (−0.01 to 0.51) 0.054
PrEP-related concerns
 Cost 0.25 0.12 (0.02 to 0.49) 0.036 0.19 0.12 (−0.04 to 0.42) 0.108
 Efficacy −0.03 0.13 (−0.27 to 0.22) 0.832        
 Side effects 0.22 0.12 (−0.02 to 0.45) 0.068        

Bold p-values indicate statistical significance at p<0.05.

B, unstandardized beta; CI, confidence interval; SE, standard error.